Lord's Mark Industries Reports ₹82 Crore Profit in H1 FY27 with Q2 Growth
Lord's Mark Industries reported a consolidated revenue of ₹718.77 crore and a PAT of ₹82.01 crore for H1 FY27, surpassing its full-year FY26 revenue and profit. Q2 revenue rose 34% quarter-on-quarter to ₹411.09 crore, with PAT increasing 47%. EBITDA margin improved to 18.8% in Q2. The company plans to launch dialysis exports, sickle cell and breast cancer screening products, and expand sales in the UK, US, and Caribbean between December 2026 and March 2027.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (76/100). Lens Score 44/100.
Outlets measured: news18, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–78/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 16 Nov, 11:54 am. Other outlets followed.
